Device Trial Radar · NCT05711316
The BD Liverty™ TIPS Stent Graft Study
Last checked: Nov 19, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
177
Actual
Start
Aug 8, 2023
Primary completion
Jun 23, 2025
Study completion Jan 11, 2027
Sponsor
- Lead sponsor
- C. R. BardPublic (BDX)
- Sponsor type
- Industry
- First posted
- Feb 3, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension from cirrhosis. This includes recurrent or refractory ascites, hepatic hydrothorax, and/or variceal bleeding (esophageal and/or gastric).
Conditions
- Portal Hypertension
- TIPS
Interventions
BD Liverty™ TIPS Stent GraftDevice
Treatment of portal hypertension complications with placement of the BD Liverty™ TIPS Stent Graft after creation of a Transjugular Intrahepatic Portosystemic Shunt.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Freedom from Major Complications through 30 days post-Index ProcedureTime frame: 30 days
- Freedom from Shunt Dysfunction through 6 months post-Treatment CompletionTime frame: 6 months
Locations
26 sites in 3 countries. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
Georgetown University
Washington D.C., District of Columbia
Trustees of Indiana University ("IU")/ Indiana University Health, Inc.
Indianapolis, Indiana
23 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.